Pardes Biosciences Ownership 2024 | Who Owns Pardes Biosciences Now?
Institutional Ownership
0.05%
Insider Ownership
13.47%
Retail Ownership
86.48%
Institutional Holders
1.00
Pardes Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COWEN AND COMPANY, LLC | - | - | - | -76,839 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -151 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -31,442 | -100.00% | - | Sep 30, 2023 |
| FMR LLC | - | - | - | -4,181 | -100.00% | - | Sep 30, 2023 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -300 | -100.00% | - | Sep 30, 2023 |
| CITIGROUP INC | - | - | - | -122 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -19,235 | -100.00% | - | Sep 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -838,362 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -24,549 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -188 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -147 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,677 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -400,000 | -100.00% | - | Sep 30, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -5,832 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -228,575 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -456,689 | -100.00% | - | Sep 30, 2023 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -430,291 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -10,080 | -100.00% | - | Sep 30, 2023 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -54,278 | -100.00% | - | Sep 30, 2023 |
Pardes Biosciences's largest institutional shareholder is COWEN AND COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COWEN AND COMPANY, LLC | - | - | - | -76,839 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -151 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -31,442 | -100.00% | - | Sep 30, 2023 |
| FMR LLC | - | - | - | -4,181 | -100.00% | - | Sep 30, 2023 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -300 | -100.00% | - | Sep 30, 2023 |
| CITIGROUP INC | - | - | - | -122 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -19,235 | -100.00% | - | Sep 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -838,362 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -24,549 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -188 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -147 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,677 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -400,000 | -100.00% | - | Sep 30, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -5,832 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -228,575 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -456,689 | -100.00% | - | Sep 30, 2023 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -430,291 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -10,080 | -100.00% | - | Sep 30, 2023 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -54,278 | -100.00% | - | Sep 30, 2023 |
The largest Pardes Biosciences shareholder by % of total assets is COWEN AND COMPANY, LLC. The company owns 0.00 shares of Pardes Biosciences (PRDS), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -41 | -100.00% | - | Sep 30, 2023 |
| CITIGROUP INC | - | - | - | -122 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -147 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -151 | -100.00% | - | Sep 30, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -188 | -100.00% | - | Sep 30, 2023 |
| STATE OF WYOMING | - | - | - | -287 | -100.00% | - | Sep 30, 2023 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -300 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -339 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,677 | -100.00% | - | Sep 30, 2023 |
| FMR LLC | - | - | - | -4,181 | -100.00% | - | Sep 30, 2023 |
| POINT72 MIDDLE EAST FZE | - | - | - | -4,501 | -100.00% | - | Sep 30, 2023 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -5,219 | -100.00% | - | Sep 30, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -5,832 | -100.00% | - | Sep 30, 2023 |
| CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -10,080 | -100.00% | - | Sep 30, 2023 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -13,120 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -19,235 | -100.00% | - | Sep 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -20,076 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Pardes Biosciences's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased -41.00 stocks of PRDS, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT V, LLC | - | - | - | -10,811,887 | -100.00% | - | Sep 30, 2023 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,902,434 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -3,791,633 | -100.00% | - | Sep 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -838,362 | -100.00% | - | Sep 30, 2023 |
| ARENA CAPITAL ADVISORS, LLC- CA | - | - | - | -826,104 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -456,689 | -100.00% | - | Sep 30, 2023 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -430,291 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -400,000 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -266,061 | -100.00% | - | Sep 30, 2023 |
| TERRAPIN ASSET MANAGEMENT, LLC | - | - | - | -244,550 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -228,575 | -100.00% | - | Sep 30, 2023 |
| COWEN AND COMPANY, LLC | - | - | - | -76,839 | -100.00% | - | Sep 30, 2023 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -54,278 | -100.00% | - | Sep 30, 2023 |
| IEQ CAPITAL, LLC | - | - | - | -50,000 | -100.00% | - | Sep 30, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -47,664 | -100.00% | - | Sep 30, 2023 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -47,469 | -100.00% | - | Sep 30, 2023 |
| JBF CAPITAL, INC. | - | - | - | -43,998 | -100.00% | - | Sep 30, 2023 |
| MBB PUBLIC MARKETS I LLC | - | - | - | -39,400 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -31,442 | -100.00% | - | Sep 30, 2023 |
| JACKSON SQUARE CAPITAL, LLC | - | - | - | -26,396 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Pardes Biosciences's biggest institutional seller is FORESITE CAPITAL MANAGEMENT V, LLC. The company sold -10.81M shares of PRDS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT V, LLC | - | - | - | -10,811,887 | -100.00% | - | Sep 30, 2023 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,902,434 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -3,791,633 | -100.00% | - | Sep 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -838,362 | -100.00% | - | Sep 30, 2023 |
| ARENA CAPITAL ADVISORS, LLC- CA | - | - | - | -826,104 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -456,689 | -100.00% | - | Sep 30, 2023 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -430,291 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -400,000 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -266,061 | -100.00% | - | Sep 30, 2023 |
| TERRAPIN ASSET MANAGEMENT, LLC | - | - | - | -244,550 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -228,575 | -100.00% | - | Sep 30, 2023 |
| COWEN AND COMPANY, LLC | - | - | - | -76,839 | -100.00% | - | Sep 30, 2023 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -54,278 | -100.00% | - | Sep 30, 2023 |
| IEQ CAPITAL, LLC | - | - | - | -50,000 | -100.00% | - | Sep 30, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -47,664 | -100.00% | - | Sep 30, 2023 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -47,469 | -100.00% | - | Sep 30, 2023 |
| JBF CAPITAL, INC. | - | - | - | -43,998 | -100.00% | - | Sep 30, 2023 |
| MBB PUBLIC MARKETS I LLC | - | - | - | -39,400 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -31,442 | -100.00% | - | Sep 30, 2023 |
| JACKSON SQUARE CAPITAL, LLC | - | - | - | -26,396 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -24,549 | -100.00% | - | Sep 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -20,076 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -19,235 | -100.00% | - | Sep 30, 2023 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -13,120 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -10,080 | -100.00% | - | Sep 30, 2023 |
| CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -5,832 | -100.00% | - | Sep 30, 2023 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -5,219 | -100.00% | - | Sep 30, 2023 |
| POINT72 MIDDLE EAST FZE | - | - | - | -4,501 | -100.00% | - | Sep 30, 2023 |
| FMR LLC | - | - | - | -4,181 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,677 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -339 | -100.00% | - | Sep 30, 2023 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -300 | -100.00% | - | Sep 30, 2023 |
| STATE OF WYOMING | - | - | - | -287 | -100.00% | - | Sep 30, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -188 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -151 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -147 | -100.00% | - | Sep 30, 2023 |
| CITIGROUP INC | - | - | - | -122 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -41 | -100.00% | - | Sep 30, 2023 |
Pardes Biosciences's largest sold out institutional shareholder by shares sold is FORESITE CAPITAL MANAGEMENT V, LLC, sold -10.81M shares, valued at -, as of undefined.
Pardes Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Collaborative Investment Series Trust | 0.30% | 47,088 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.08% | 283,073 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.05% | 257,233 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 51,000 | - | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 16,509 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 74,431 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,775 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,100 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 7,070 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 965,395 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 209,002 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,125 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 49,472 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,730 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 19,235 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,329 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 126,515 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 6,082 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 688 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 16,706 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,000 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,747 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 298,632 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 259 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 117,853 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 12,637 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 434 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 99,234 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 129 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,009 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 5,609 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,910 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 19 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 4,060 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,934 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 23,300 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 143 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 7,250 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 89,951 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 14,511 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 223 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 25,338 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 5,635 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 962 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 882 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,290 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 4,050 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,806 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 703 | - | - | Mar 31, 2024 |
Pardes Biosciences's largest mutual fund holder by % of total assets is "Collaborative Investment Series Trust", owning 47.09K shares, compromising 0.30% of its total assets.
Pardes Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Sep, 23 | 1 | -98.31% |
| 30 Jun, 23 | 59 | - |
| 31 Mar, 23 | 59 | -6.35% |
| 31 Dec, 22 | 63 | - |
| 30 Sep, 22 | 63 | -3.08% |
| 30 Jun, 22 | 65 | 14.04% |
| 31 Mar, 22 | 57 | 39.02% |
| 31 Dec, 21 | 41 | - |
As of 30 Sep 23, 1 institutions are holding Pardes Biosciences's shares, representing a decrease of -98.31% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Sep, 23 | 31,037 | -99.91% |
| 30 Jun, 23 | 35,308,744 | -4.13% |
| 31 Mar, 23 | 36,830,553 | -2.48% |
| 31 Dec, 22 | 37,768,632 | -19.90% |
| 30 Sep, 22 | 47,154,206 | 0.73% |
| 30 Jun, 22 | 46,814,416 | 19.73% |
| 31 Mar, 22 | 39,101,317 | 11.61% |
| 31 Dec, 21 | 35,033,694 | - |
Pardes Biosciences (PRDS) has 31.04K shares outstanding as of 30 Sep 23, down -99.91% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Sep, 23 | 0.05% | 0.00% |
| 30 Jun, 23 | 58.64% | 1.54% |
| 31 Mar, 23 | 61.62% | 1.46% |
| 31 Dec, 22 | 64.98% | 1.00% |
| 30 Sep, 22 | 80.77% | 1.23% |
| 30 Jun, 22 | 81.15% | 1.73% |
| 31 Mar, 22 | 68.55% | 1.80% |
| 31 Dec, 21 | 61.72% | - |
As of 30 Sep 23, Pardes Biosciences is held by 0.05% institutional shareholders, representing a 0.00% growth compared to 30 Jun 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Sep, 23 | - | -100.00% |
| 30 Jun, 23 | 29 | 26.09% |
| 31 Mar, 23 | 23 | -25.81% |
| 31 Dec, 22 | 31 | 3.33% |
| 30 Sep, 22 | 30 | -11.76% |
| 30 Jun, 22 | 34 | - |
| 31 Mar, 22 | 34 | -17.07% |
| 31 Dec, 21 | 41 | - |
- institutional shareholders have increased their position in PRDS stock as of 30 Sep 23 compared to 29 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Sep, 23 | 1 | -95.65% |
| 30 Jun, 23 | 23 | 43.75% |
| 31 Mar, 23 | 16 | 33.33% |
| 31 Dec, 22 | 12 | -14.29% |
| 30 Sep, 22 | 14 | -26.32% |
| 30 Jun, 22 | 19 | 46.15% |
| 31 Mar, 22 | 13 | - |
| 31 Dec, 21 | - | - |
1 institutional shareholders have reduced their position in PRDS stock as of 30 Sep 23 compared to 23 in the previous quarter (a -95.65% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep, 23 | 1 | -98.31% | 31,037 | -99.91% | 0.05% | 0.00% | - | -100.00% | 1 | -95.65% |
| 30 Jun, 23 | 59 | - | 35,308,744 | -4.13% | 58.64% | 1.54% | 29 | 26.09% | 23 | 43.75% |
| 31 Mar, 23 | 59 | -6.35% | 36,830,553 | -2.48% | 61.62% | 1.46% | 23 | -25.81% | 16 | 33.33% |
| 31 Dec, 22 | 63 | - | 37,768,632 | -19.90% | 64.98% | 1.00% | 31 | 3.33% | 12 | -14.29% |
| 30 Sep, 22 | 63 | -3.08% | 47,154,206 | 0.73% | 80.77% | 1.23% | 30 | -11.76% | 14 | -26.32% |
| 30 Jun, 22 | 65 | 14.04% | 46,814,416 | 19.73% | 81.15% | 1.73% | 34 | - | 19 | 46.15% |
| 31 Mar, 22 | 57 | 39.02% | 39,101,317 | 11.61% | 68.55% | 1.80% | 34 | -17.07% | 13 | - |
| 31 Dec, 21 | 41 | - | 35,033,694 | - | 61.72% | - | 41 | - | - | - |
Pardes Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Pardes Biosciences's stock was made by Tananbaum James B. on Aug 31 2023, selling 16,813,146 shares at - per share (valued at $1.68K).
Pardes Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 4 | 42 | 9.52% |
| Q2 2023 | 11 | - | - |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 6 | - | - |
| Q1 2022 | 7 | - | - |
| Q4 2021 | 19 | 25 | 76.00% |
| Q1 2021 | 1 | 4 | 25.00% |
4 total buy trades, and 42 total sell trades (buy/sell ratio of 0.10%) were made by Pardes Biosciences's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q2 2023 | 2 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q1 2021 | 1 | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Pardes Biosciences's stocks.
Pardes Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| IPSC | Century Therapeutics, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| ASMB | Assembly Biosciences, Inc. |
| OVID | Ovid Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| TIL | Instil Bio, Inc. |
| STTK | Shattuck Labs, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
PRDS Ownership FAQ
Who Owns Pardes Biosciences?
Pardes Biosciences is owned by institutional shareholders (0.05%), insiders (13.47%), and public (86.48%). The largest institutional shareholder of Pardes Biosciences is COWEN AND COMPANY, LLC (0% of total shares) and the top mutual fund owner is Collaborative Investment Series Trust (0.30% of total shares).
Who are the major institutional shareholders of Pardes Biosciences?
Pardes Biosciences's major institutional shareholders are COWEN AND COMPANY, LLC, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, FMR LLC, and NEW YORK STATE COMMON RETIREMENT FUND. The top five shareholders own together 0% of the company's share outstanding.
How many Pardes Biosciences shareholders are there?
As of Sep 2023, there are 1 institutional shareholders of Pardes Biosciences.
What percentage of Pardes Biosciences is owned by COWEN AND COMPANY, LLC?
COWEN AND COMPANY, LLC owns 0 shares of Pardes Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Pardes Biosciences is owned by WELLS FARGO & COMPANY/MN?
As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Pardes Biosciences (PRDS), compromising 0% of the company, valued at $0.
What percentage of Pardes Biosciences is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Pardes Biosciences. The company owns 0 of the company's shares outstanding (worth $0).